SIMPLEX TRADING, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 6 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$40,075
+12.8%
330,600
+6.5%
0.03%
+10.3%
Q2 2023$35,535
+26.2%
310,300
+51.9%
0.03%
+16.0%
Q1 2023$28,158
+570.7%
204,300
+530.6%
0.02%
+400.0%
Q4 2022$4,198
-99.6%
32,400
+260.0%
0.01%
+400.0%
Q3 2022$994,000
+455.3%
9,000
+275.0%
0.00%
Q2 2022$179,000
-76.6%
2,400
-75.5%
0.00%
-100.0%
Q1 2022$765,000
-87.5%
9,800
-85.5%
0.00%
-83.3%
Q4 2021$6,096,000
+103.9%
67,700
+77.2%
0.01%
+100.0%
Q3 2021$2,989,000
+0.7%
38,2000.0%0.00%0.0%
Q2 2021$2,969,00038,200
+5227.8%
0.00%
Q1 2021$0
-100.0%
717
-24.5%
0.00%
-100.0%
Q4 2020$16,196,000
+200.4%
950
+147.4%
0.02%
+200.0%
Q3 2020$5,392,000
+39.5%
384
+59.3%
0.01%
+16.7%
Q2 2020$3,864,000
+75.6%
241
+7.1%
0.01%
+50.0%
Q1 2020$2,200,000
-85.5%
225
-80.9%
0.00%
-87.9%
Q4 2019$15,200,000
+98.3%
1,178
+15.7%
0.03%
+50.0%
Q3 2019$7,667,000
-47.0%
1,018
+6.9%
0.02%
-43.6%
Q2 2019$14,465,000
+46.7%
952
+15.1%
0.04%
+44.4%
Q1 2019$9,857,000
+44.5%
827
+32.3%
0.03%
+35.0%
Q4 2018$6,820,000
+26.1%
625
+86.6%
0.02%
+17.6%
Q3 2018$5,410,000
-45.8%
335
-55.6%
0.02%
-56.4%
Q2 2018$9,979,000
+83058.3%
755
+906.7%
0.04%
+3800.0%
Q1 2018$12,000
-72.7%
75
-93.8%
0.00%
-50.0%
Q4 2017$44,000
-77.1%
1,206
+22.1%
0.00%
-75.0%
Q3 2017$192,000
+3.8%
988
+244.3%
0.01%0.0%
Q2 2017$185,000
-44.8%
287
-35.2%
0.01%
-42.9%
Q1 2017$335,000
-27.2%
443
-52.6%
0.01%
-48.1%
Q4 2016$460,000
-8.2%
934
-75.2%
0.03%
-20.6%
Q3 2016$501,000
-37.8%
3,761
+2.5%
0.03%
-37.0%
Q2 2016$806,000
+138.5%
3,670
+548.4%
0.05%
+100.0%
Q1 2016$338,000
+724.4%
566
+9.7%
0.03%
+800.0%
Q4 2015$41,000
-58.2%
516
+141.1%
0.00%
-57.1%
Q3 2015$98,000
+53.1%
214
+67.2%
0.01%
+40.0%
Q2 2015$64,000
-63.2%
128
-19.0%
0.01%
-75.0%
Q1 2015$174,000
-45.1%
158
-22.2%
0.02%
-47.4%
Q4 2014$317,0002030.04%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 962$16,401,0000.61%
GROUP ONE TRADING, L.P. 183,600$31,302,0000.05%
SIMPLEX TRADING, LLC 950$16,196,0000.02%
JPMORGAN CHASE & CO 417,600$71,197,0000.01%
IMC-Chicago, LLC 33,800$5,763,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders